SAR-20347产品图

SAR-20347

收藏
  • ¥890 - 4490
  • Solarbio已认证
  • 北京
  • IS3350
  • 2026年08月13日
    avatar
    品牌商
    14 年钻石会员
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 保存条件:

      Powder:2-8℃,2 years;Insolvent(母液):-20℃,6 months;-80℃,1 year

    • 保质期:

      Powder:2-8℃,2 years;Insolvent(母液):-20℃,6 months;-80℃,1 year

    • 英文名:

      SAR-20347

    • 库存:

      999

    • 供应商:

      北京索莱宝科技有限公司

    • CAS号:

      1450881-55-6

    • 规格:

      5mg/10mg/25mg/50mg

    规格:5mg产品价格:¥890.00
    规格:10mg产品价格:¥1440.00
    规格:25mg产品价格:¥2890.00
    规格:50mg产品价格:¥4490.00
    CAS1450881-55-6
    英文名称SAR-20347
    别名CPDD1211;SAR-20347;SAR20347
    分子式C21H18ClFN4O4
    分子量444.84
    规格5mg ; 10mg ; 25mg ; 50mg
    溶解性Soluble in DMSO ≥10mg/mL
    纯度≥98%
    外观(性状)Solid
    储存条件Powder:2-8℃,2 years;Insolvent(母液):-20℃,6 months;-80℃,1 year
    运输条件冷藏运输
    MDLMFCD28502117
    SMILESC1COCCN1C(=O)C2=CC=C(C=C2)NC3=C(N=C(O3)C4=C(C=CC=C4Cl)F)C(=O)N
    InChIKeyC1COCCN1C(=O)C2=CC=C(C=C2)NC3=C(N=C(O3)C4=C(C=CC=C4Cl)F)C(=O)N
    InChIInChI=1S/C21H18ClFN4O4/c22-14-2-1-3-15(23)16(14)19-26-17(18(24)28)20(31-19)25-13-6- 4-12(5-7-13)21(29)27-8-10-30-11-9-27/h1-7,25H,8-11H2,(H2,24,28)
    PubChem CID71727668
    靶点JAK;Tyk2
    通路JAK/STAT Signaling
    背景说明SAR-20347 是 TYK2,JAK1,JAK2 和 JAK3 的抑制剂。
    生物活性SAR-20347 is an inhibitor of TYK2, JAK1, JAK2 and JAK3 with IC50s of 0.6, 23, 26 and 41 nM, respectively.[1]
    In VitroWhen NK-92 cells are stimulated with IL-12, SAR-20347 potently inhibits IL-12-mediated STAT4 phosphorylation, a TYK2-dependent event, with an IC50 of 126 nM. SAR-20347 demonstrates a selectivity of TYK2>JAK1>JAK2>JAK3. Cells without IL-12 in the culture media have no measureable IFN-γ, while cells incubated with IL-12 and SAR-20347 demonstrate dose-dependent inhibition of IFN-γ production. SAR-20347 dose-dependently inhibits the production of secreted embryonic alkaline phosphatase (SEAP) with greatest inhibition occurring with 5 μM of SAR-20347 in these experiments[1].
    In Vivo60 mg/kg SAR-20347 inhibits the production of IFN-γ in the serum by 91% compare to vehicle-treated animals, demonstrating that SAR-20347 can inhibit TYK2 signaling in vivo. SAR-20347 treatment significantly reduces IL-17 production as measured by average signal intensity, consistent with the gene expression analysis[1].
    细胞实验Cells are plated in a 96-well v-bottom plate in starvation medium, incubated with SAR-20347 (0.5% DMSO) for 20 minutes at 37°C, 5% CO2, and stimulated with individual cytokines. P-STAT levels are measured in duplicate using MSD plates following the manufacturers instructions (MSD). The IC50 is determined by subtracting background (no cytokine) and relative to DMSO/cytokine control[1].
    动物实验Female 7 to 9 week old C57BL/6 mice are used. Mice are administered vehicle or 50 mg/kg SAR-20347 by oral gavage 30 minutes prior to application of 62.5 mg 5% imiquimod cream or control cream. Another dose of vehicle or 50 mg/kg SAR-20347 is given 5.5 hours following the first dose. This treatment is repeated for 5 days and on day 3 and 4, animals are injected with 100 uL saline to prevent dehydration. Each day, the mice are assessed by the same researcher for redness. On the 6th day, the animals are euthanized and photographs are taken[1].
    激酶实验Kinases are prepared in Base Reaction Buffer (20 mM Hepes pH 7.5, 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/mL BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO) and substrate is added with 1.5 mM CaCl2, 16 μg/mL Calmodulin, and 2 mM MnCl2. Varying concentrations of SAR-20347 in DMSO are added to the kinase reaction along with 10 μM 33P-ATP (activity 0.01 μCi/μL final) for IC50 determination[1].
    数据来源文献[1]. Works MG, et al. Inhibition of TYK2 and JAK1 ameliorates imiquimod-induced psoriasis-like dermatitis by inhibiting IL-22 and the IL-23/IL-17 axis. J Immunol. 2014 Oct 1;193(7):3278-87.
    单位瓶
    表格1|*|1mg|5mg|10mg|$$|1mM|12.8205mL|64.1026mL|128.2051mL|$$|5mM|2.5641mL|12.8205mL|25.641mL|$$|10mM|1.2821mL|6.4103mL|12.8205mL|

    产品细节图片1

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    相关实验
    • Heterologous Expression and Affinity Purification of Eukaryotic Membrane Proteins in View of Functional and Structural Studies: The Example of the Sar

      Heterologous SERCA1a Ca2+ -ATPase (sarco-endoplasmic reticulum Ca2+ -adenosine triphosphatase isoform 1a) from rabbit was expressed in yeast Saccharomyces cerevisiae as a fusion protein, with a biotin acceptor domain (BAD) linked to the SERCA

    • 三句话读懂一篇 CNS:咖啡竟可降低心律失常风险;转入肥胖基

      21 日,北京大学刘颖及陈杰教授团队在 Nature 杂志上发表研究论文 SAR1B senses leucine levels to regulate mTORC1 signalling,该研究发现 SAR1B 是一种保守的亮氨酸感应器,能够调节 mTOR 复合物 1 从而响应细胞内亮氨酸的水平。图 5:来源 Nature6. Nature:肠道炎症影响嗅觉在以往的认知中,嗅觉与大脑、鼻子息息相关。2021 年 7 月 21 日,美国加州诺瓦托巴克老年研究所 Heinrich Jasper 教授

    • Neuron:北大陈雷研究组报道胞内钙离子对 TRPC3/6 通道调控的机制

      活性 CBS3 对 DAG 激活的 TRPC3/6 电流同样产生调节作用。 结构显示在 FSGS 疾病中发现的 TRPC6 GOF 点突变都分布于胞内区亚基间相互作用的界面上,有可能破坏了亚基间的相互作用。为了验证此假说,作者们解析了 GOF 突变体的结构,并通过电生理和热稳定性实验发现 GOF 突变体减弱了抑制性 Ca2+ 结合位点(CBS1)的作用,使胞内区结构变得松散,从而打开了阳离子从胞质内空腔向胞质区流出的孔道。 最后作者们解析了 BTDM 以及 SAR7334 与 TRPC6 结合的高分

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥940
    北京索莱宝科技有限公司
    2026年08月14日询价
    询价
    上海雅心生物技术有限公司
    2026年10月17日询价
    询价
    北京诺博莱德科技有限公司
    2025年11月19日询价
    ¥135
    翌圣生物科技(上海)股份有限公司
    2026年10月16日询价
    ¥200
    上海彩佑实业有限公司
    2025年07月14日询价
    SAR-20347
    ¥890 - 4490